- published: 15 Sep 2011
- views: 24766
Create your page here
-
remove the playlistAstrazeneca
- remove the playlistAstrazeneca
back to playlist
Listen to David Smoley, Chief Information Officer, AstraZeneca discuss how Box has enabled the company to reinforce its cloud strategy. Learn more about our customers here: box.com/customers
- published: 15 Sep 2015
- views: 1824
Learn from AstraZeneca’s students about the exciting opportunities our graduate programmes have to offer. Learn more about how you can join us: http://www.astrazenecacareers.com/students/
- published: 16 Sep 2015
- views: 1460
Astrazeneca Commercial 2016 Super Bowl Commercial. In this Super Bowl 50 commercial, a man nervously sits in a cafe drinking a coffee when he hears the toilet flush in the background. The word "Envy" flashes on screen, and a smiling man walks out of the bathroom.
Astrazeneca Commercial
Astrazeneca super bowl
Astrazeneca super bowl commercial
Astrazeneca super bowl ad
Astrazeneca super bowl 50
Astrazeneca super bowl 2016
Astrazeneca super bowl 2016 commercial
Astrazeneca super bowl commercial 2016
Astrazeneca super bowl 50 commercial
Astrazeneca ad
#Astrazeneca
#Commercial
#2016
#Super
#Bowl
#Commercial
https://www.youtube.com/channel/UCVPmZ9IrkSGUuCii7xPjiaQ
- published: 08 Feb 2016
- views: 282
We push the boundaries of science to deliver life-changing medicines.
- published: 11 Dec 2014
- views: 5311
AstraZeneca today revealed the proposed designs for its new Global R&D; Centre and Corporate Headquarters in Cambridge in the UK. The plans for the new facility, which will be located on the Cambridge Biomedical Campus (CBC), include designs for the Global Centre, an R&D; Enabling Building and an Energy Centre. Read more at astrazeneca.com
- published: 18 Jul 2014
- views: 10262
Scientific achievement is full of endeavor and never giving up. Pushing the boundaries of science has led us to where we are today. The human genome project revolutionized medical science—giving the world detailed information about the structure, organization and function of the complete set of human genes. This is been pushing the boundaries of what is possible. At IMED—we share this approach and passion.
Since 2010, we have built upon AstraZeneca’s strong heritage of drug discovery and development to lay the foundations for a bright future. From target identification to the end of phase two trials, our research is focused on our core therapy areas of oncology, respiratory and inflammation, cardiovascular and metabolic disease, while we remain optimistic in neuroscience and infection.
We have built a team of outstanding scientists with diverse experience and a broad range of skills driving forward research to push the boundaries of medical science. We are committed to create an environment that is open for collaboration for our people and our academic and biotech partners for scientific breakthroughs. We are fostering a culture where science thrives, one that is collaborative, agile, dynamic and entrepreneurial.
We have great pride in the breakthroughs we have made, the medicines we have developed, and the lives our science has saved. But the challenges that remain are the most complex and involved. Tackling them requires a new way of thinking. This is how we work, we do it in a way that reflects AstraZeneca’s shared values. It’s how we deliver life changing medicines to patients around the world.
- published: 14 Nov 2014
- views: 3574
Listen to our Chief Information Officer, Dave Smoley, describe the exciting IT transformation journey happening at AstraZeneca!
- published: 02 Sep 2014
- views: 2657
When leading global pharmaceutical company AstraZeneca decided to take a fresh look at what it meant to be an 'employer of choice' in its Australian operations in 2009, they went all out and decided to have a bit of fun in the process. They set out to create a strong culture of recognition across their remarkably diverse workforce and at the heart of their plans was a small blue mascot -- 'Charlie' -- who quickly became synonymous with recognition and reward. Four years on, he is still an immensely popular and recognisable figure across the organisation.
- published: 23 Feb 2014
- views: 2051
Watch to find out what attracted Dapo Ajayi, Chief Procurement Officer at AstraZeneca to her CPO role, her vision for the future of procurement and more. Plus, click here to search jobs by career area to view open procurement positions at AstraZeneca: http://bit.ly/1ySKWng
- published: 19 Nov 2014
- views: 2375
► Subscribe to the Financial Times on YouTube: http://bit.ly/FTimeSubs
AstraZeneca has won extended US approval for a pipeline drug but, as Lex's Oliver Ralph and Robert Armstrong discuss, it needs more good news to stem its patent expiration problem.
For more video content from the Financial Times, visit http://www.FT.com/video
Twitter https://twitter.com/ftvideo
Facebook https://www.facebook.com/financialtimes
- published: 05 Sep 2015
- views: 514
Pfizer's fourth and 'final' takeover approach for the UK pharmaceuticals group has been rejected. Lex's Joseph Cotterill and Robert Armstrong discuss where this leaves the two companies.
For more video content from the Financial Times, visit http://www.FT.com/video
Subscribe to the Financial Times on YouTube; http://goo.gl/vUQx5k
Twitter https://twitter.com/ftvideo
Facebook https://www.facebook.com/financialtimes
- published: 19 May 2014
- views: 1301
AstraZeneca plc (LSE: AZN, OMX: AZN) is a British multinational pharmaceutical and biologics company headquartered in London, United Kingdom. It is the world's fifth-largest pharmaceutical company measured by 2009 prescription drug sales (after Pfizer, Novartis, Sanofi and GlaxoSmithKline) and has operations in over 100 countries. It has a portfolio of products for major disease areas including cancer, cardiovascular, gastrointestinal, infection, neuroscience, respiratory and inflammation. The company was founded in 1999 through the merger of the Sweden-based Astra AB and UK-based Zeneca Group.
AstraZeneca has a primary listing on the London Stock Exchange and is a constituent of the FTSE 100 Index. It had a market capitalisation of approximately £39.5 billion as of 23 December 2011, the 10th-largest of any company with a primary listing on the London Stock Exchange. It has secondary listings on the New York Stock Exchange and the OMX exchange.
Astra AB was founded in 1913 by 400 doctors and apothecaries in Södertälje, Sweden. In 1993 British ICI demerged its pharmaceuticals businesses and its agrochemicals and specialties businesses, to form Zeneca Group plc, and in 1999 Astra and Zeneca Group merged to form AstraZeneca plc.
This page contains text from Wikipedia, the Free Encyclopedia -
http://en.wikipedia.org/wiki/AstraZeneca
This article is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License, which means that you can copy and modify it as long as the entire work (including additions) remains under this license.
This article is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License, which means that you can copy and modify it as long as the entire work (including additions) remains under this license.
- Loading...
-
3:46The AstraZeneca story
The AstraZeneca story -
2:56AstraZeneca Employees use Box to Drive Change through Innovation
AstraZeneca Employees use Box to Drive Change through InnovationAstraZeneca Employees use Box to Drive Change through Innovation
Listen to David Smoley, Chief Information Officer, AstraZeneca discuss how Box has enabled the company to reinforce its cloud strategy. Learn more about our customers here: box.com/customers -
4:53AstraZeneca Graduate Programme
AstraZeneca Graduate ProgrammeAstraZeneca Graduate Programme
Learn from AstraZeneca’s students about the exciting opportunities our graduate programmes have to offer. Learn more about how you can join us: http://www.astrazenecacareers.com/students/ -
2:17Astrazeneca Commercial 2016 Super Bowl Commercial
Astrazeneca Commercial 2016 Super Bowl CommercialAstrazeneca Commercial 2016 Super Bowl Commercial
Astrazeneca Commercial 2016 Super Bowl Commercial. In this Super Bowl 50 commercial, a man nervously sits in a cafe drinking a coffee when he hears the toilet flush in the background. The word "Envy" flashes on screen, and a smiling man walks out of the bathroom. Astrazeneca Commercial Astrazeneca super bowl Astrazeneca super bowl commercial Astrazeneca super bowl ad Astrazeneca super bowl 50 Astrazeneca super bowl 2016 Astrazeneca super bowl 2016 commercial Astrazeneca super bowl commercial 2016 Astrazeneca super bowl 50 commercial Astrazeneca ad #Astrazeneca #Commercial #2016 #Super #Bowl #Commercial https://www.youtube.com/channel/UCVPmZ9IrkSGUuCii7xPjiaQ -
1:32AstraZeneca and MedImmune: Our Purpose
AstraZeneca and MedImmune: Our PurposeAstraZeneca and MedImmune: Our Purpose
We push the boundaries of science to deliver life-changing medicines. -
1:01AstraZeneca reveals designs for new Global R&D; Centre and Corporate Headquarters in Cambridge, UK
AstraZeneca reveals designs for new Global R&D; Centre and Corporate Headquarters in Cambridge, UKAstraZeneca reveals designs for new Global R&D; Centre and Corporate Headquarters in Cambridge, UK
AstraZeneca today revealed the proposed designs for its new Global R&D; Centre and Corporate Headquarters in Cambridge in the UK. The plans for the new facility, which will be located on the Cambridge Biomedical Campus (CBC), include designs for the Global Centre, an R&D; Enabling Building and an Energy Centre. Read more at astrazeneca.com -
2:19AstraZeneca's IMED Biotech Unit
AstraZeneca's IMED Biotech UnitAstraZeneca's IMED Biotech Unit
Scientific achievement is full of endeavor and never giving up. Pushing the boundaries of science has led us to where we are today. The human genome project revolutionized medical science—giving the world detailed information about the structure, organization and function of the complete set of human genes. This is been pushing the boundaries of what is possible. At IMED—we share this approach and passion. Since 2010, we have built upon AstraZeneca’s strong heritage of drug discovery and development to lay the foundations for a bright future. From target identification to the end of phase two trials, our research is focused on our core therapy areas of oncology, respiratory and inflammation, cardiovascular and metabolic disease, while we remain optimistic in neuroscience and infection. We have built a team of outstanding scientists with diverse experience and a broad range of skills driving forward research to push the boundaries of medical science. We are committed to create an environment that is open for collaboration for our people and our academic and biotech partners for scientific breakthroughs. We are fostering a culture where science thrives, one that is collaborative, agile, dynamic and entrepreneurial. We have great pride in the breakthroughs we have made, the medicines we have developed, and the lives our science has saved. But the challenges that remain are the most complex and involved. Tackling them requires a new way of thinking. This is how we work, we do it in a way that reflects AstraZeneca’s shared values. It’s how we deliver life changing medicines to patients around the world. -
4:13AstraZeneca - Recruitment - Dave Smoley CIO
AstraZeneca - Recruitment - Dave Smoley CIOAstraZeneca - Recruitment - Dave Smoley CIO
Listen to our Chief Information Officer, Dave Smoley, describe the exciting IT transformation journey happening at AstraZeneca! -
3:56Employee Recognition at AstraZeneca
Employee Recognition at AstraZenecaEmployee Recognition at AstraZeneca
When leading global pharmaceutical company AstraZeneca decided to take a fresh look at what it meant to be an 'employer of choice' in its Australian operations in 2009, they went all out and decided to have a bit of fun in the process. They set out to create a strong culture of recognition across their remarkably diverse workforce and at the heart of their plans was a small blue mascot -- 'Charlie' -- who quickly became synonymous with recognition and reward. Four years on, he is still an immensely popular and recognisable figure across the organisation. -
3:45Dapo Ajayi - AstraZeneca Chief Procurement Officer
Dapo Ajayi - AstraZeneca Chief Procurement OfficerDapo Ajayi - AstraZeneca Chief Procurement Officer
Watch to find out what attracted Dapo Ajayi, Chief Procurement Officer at AstraZeneca to her CPO role, her vision for the future of procurement and more. Plus, click here to search jobs by career area to view open procurement positions at AstraZeneca: http://bit.ly/1ySKWng -
2:29AstraZeneca's bucket problem | Lex
AstraZeneca's bucket problem | LexAstraZeneca's bucket problem | Lex
► Subscribe to the Financial Times on YouTube: http://bit.ly/FTimeSubs AstraZeneca has won extended US approval for a pipeline drug but, as Lex's Oliver Ralph and Robert Armstrong discuss, it needs more good news to stem its patent expiration problem. For more video content from the Financial Times, visit http://www.FT.com/video Twitter https://twitter.com/ftvideo Facebook https://www.facebook.com/financialtimes -
3:20No deal means both AstraZeneca and Pfizer will lose
No deal means both AstraZeneca and Pfizer will loseNo deal means both AstraZeneca and Pfizer will lose
Pfizer's fourth and 'final' takeover approach for the UK pharmaceuticals group has been rejected. Lex's Joseph Cotterill and Robert Armstrong discuss where this leaves the two companies. For more video content from the Financial Times, visit http://www.FT.com/video Subscribe to the Financial Times on YouTube; http://goo.gl/vUQx5k Twitter https://twitter.com/ftvideo Facebook https://www.facebook.com/financialtimes -
8:39PMQs: Cameron and Miliband on Pfizer AstraZeneca jobs
PMQs: Cameron and Miliband on Pfizer AstraZeneca jobsPMQs: Cameron and Miliband on Pfizer AstraZeneca jobs
Labour leader Ed Miliband has called for the prime minister to give assurances on the future of AstraZeneca and possible job losses in Pfizer's bid for the UK firm. David Cameron said the best thing thing to do was "get stuck in to seek the best possible guarantees" on British jobs, investment and science. The pair clashed on job numbers and a possible break up of the firm, as they looked back to previous claims about the future of Cadbury and the Royal Mail -
5:52AstraZeneca North West Apprenticeship Programme (UK)
AstraZeneca North West Apprenticeship Programme (UK)AstraZeneca North West Apprenticeship Programme (UK)
Unsure if University is for you? Apply to one of AstraZeneca's apprenticeship programmes! With opportunities in engineering, technology and more, you'll work alongside our experts while being trained and mentored along the way. http://bit.ly/1TDnmFw
- ABB Group
- ACE Limited
- Acme Markets
- Admiral Group
- Aggreko
- AGI-1067
- Agrochemicals
- AgustaWestland
- Airgas
- Alderley Park
- Alfa Laval
- Allegation
- Alliance Boots
- AlliedBarton
- AMEC
- AmerisourceBergen
- Anaesthetics
- Anastrozole
- Anglo American plc
- Annual report
- Antofagasta PLC
- Anxiety disorder
- Apothacary
- Aqua America
- Aramark
- ARM Holdings
- Ashland Inc.
- Ashmore Group
- Assa Abloy
- Astex
- Astra AB
- AstraZeneca
- Atenolol
- Atherosclerosis
- Atlas Copco
- Aviva
- BAE Systems
- Ballard Spahr
- Bambuterol
- Bandolier (journal)
- Barclays
- Beneficial Bank
- Bentley Systems
- BG Group
- BHP Billiton
- Bicalutamide
- Biotechnology
- Blackstone Group
- Blank Rome
- Blood vessel
- Boliden AB
- Boscov's
- BP
- British Land
- Brompheniramine
- BSkyB
- BT Group
- BTG
- Budesonide
- Bunzl
- Bupivacaine
- Burberry
- Business record
- Business Week
- Capita Group
- Cardiology
- Cardiovascular
- Category AstraZeneca
- Cediranib
- Cefotetan
- Centocor
- Centrica
- Cephalon
- Cheshire
- Chloroquine
- Chlortalidone
- Cigna
- Circulatory system
- Class action
- Clinical trial
- Clomethiazole
- Colonial Penn
- Comcast
- Compass Group
- Conseco
- Conspiracy (crime)
- Corporate title
- Cover story
- Cozen O'Connor
- CRH plc
- Croda International
- Crown Holdings
- Cyclacel
- Daptomycin
- Deceptive
- Dechert
- Delaware Valley
- Delmarva Power
- Demerged
- Diabetes
- Diageo
- Disufenton sodium
- Document
- Dow Chemical
- DrugScope
- Duane Morris
- DuPont
- Eastern Europe
- EBay
- Editor in chief
- Electrolux
- Enalapril
- Enantiomer
- Ericsson
- Esomeprazole
- Espionage
- Evraz
- Exelon
- Experian
- Felodipine
- FluMist
- Forman Mills
- Formoterol
- Fortune 500
- Foscarnet
- Fraud
- Fresnillo plc
- FTSE 100 Index
- Fulvestrant
- G4S
- Galida
- Gastroenterology
- Gastrointestinal
- GE Healthcare
- Gefitinib
- Generic drug
- Genus plc
- Getinge Group
- GKN
- GlaxoSmithKline
- Glencore
- Goserelin
- GSI Commerce
- H&M;
- Hammerson
- Handelsbanken
- Harald zur Hausen
- Hargreaves Lansdown
- Heart problems
- Hercules Inc.
- Hewlett-Packard
- HSBC
- HSBC Bank USA
- Hydrochlorothiazide
- ICAP (company)
- IMI plc
- Imperial Tobacco
- Infection
- Infectious disease
- Inflammation
- ING Group
- Intercytex
- International Power
- Intertek
- Investor AB
- ITV plc
- Johnson & Johnson
- Johnson Matthey
- Kazakhmys
- KGB
- Kingfisher plc
- Land Securities
- Lawsuit
- Lawsuits
- Legal & General
- Lexxel
- Liberty Media
- Lidocaine
- Lidocaine prilocaine
- Lisinopril
- Lloyds Banking Group
- Logimax
- Lundin Petroleum
- MAB Paints
- Madrid
- Man Group
- Marcia Angell
- Marks & Spencer
- McNeil Laboratories
- MedImmune
- Meggitt
- Mepivacaine
- Meropenem
- Metoprolol
- Modern Times Group
- Monk's Heath
- Morrisons
- Motavizumab
- Mölndal
- Naproxen
- National Grid plc
- Neoware
- Net income
- Neurology
- Neuroscience
- Next (clothing)
- Nif-Ten
- Nifedipine
- Nokia
- Nordea
- Norfloxacin
- Novartis
- OJSC Polymetal
- Old Mutual
- Omeprazole
- OMX
- OMX Stockholm 30
- Oncology
- OpenCorporates
- Oxford BioMedica
- Palivizumab
- Pearson PLC
- PECO Energy Company
- Pep Boys
- Pepco Holdings
- Pepper Hamilton
- Personal injury
- Petrofac
- Pfizer
- Pfizer UK
- Pharmaceuticals
- Philadelphia
- Phytopharm
- Pinnacle Foods
- Placebo
- Plead guilty
- Polish Water Ice
- Portal Companies
- Portal London
- Prilocaine
- Prilosec
- Primidone
- Product liability
- Proguanil
- Propofol
- Propranolol
- Prudential plc
- Psychiatry
- Pulmonology
- Quetiapine
- QVC
- Radian Group
- Raltitrexed
- Ramipril
- Randgold Resources
- Reckitt Benckiser
- Reed Elsevier
- Renovo plc
- Resolution Limited
- Respiratory system
- Rexam
- Rio Tinto Group
- Rita's Italian Ice
- Rohm and Haas
- Rolls-Royce plc
- Ropivacaine
- Rosuvastatin
- Royal Dutch Shell
- RSA Insurance Group
- SABMiller
- Safe
- Sage Group
- Sainsbury's
- Sandvik
- Sanofi
- SAP AG
- Saul Ewing
- Scania AB
- Schroders
- Securitas AB
- Seloken XL
- Serco Group
- Severn Trent
- Sexual harassment
- Sherwin-Williams
- Shire plc
- Side effects
- Sikorsky Aircraft
- Skanska
- SKF
- Smith & Nephew
- Smiths Group
- Social medicine
- Sovereign Bank
- Specialties
- SSAB
- SSE plc
- Standard Chartered
- Standard Life
- Stefan P. Kruszewski
- Stereoisomerism
- Stern (magazine)
- Stroke
- Subaru of America
- SunGard
- Sunoco
- Swedbank
- Sweden
- Swedish Match
- Södertälje
- Tamoxifen
- Tasty Baking Company
- Tate & Lyle
- TBS GB
- TD Bank, N.A.
- Tele2
- TeliaSonera
- Template AstraZeneca
- Tenoretic
- Terbutaline
- Tesco
- The New Yorker
- The Vanguard Group
- Thrombosis
- Ticagrelor
- Ticker symbol
- Tom McKillop
- Toprol-XL
- Tullow Oil
- U.S. District Court
- UGI Corporation
- Unilever
- Unimax
- Unipath
- Unisys
- United Kingdom
- United Utilities
- Urban Outfitters
- Vandetanib
- Vectura Group
- Vedanta Resources
- Vernalis plc
- ViiV Healthcare
- Viloxazine
- ViroPharma
- Vodafone
- Volvo
- Wawa Food Market
- Weight gain
- Weir Group
- Whitbread
- Wikipedia Link rot
- Wilmington Trust
- Wolseley plc
- WPP plc
- WSFS Bank
- Ximelagatran
- Xstrata
- Xyloproct
- Yacht
- Yahoo!
- Zafirlukast
- Zeneca
- Zestoretic
- Zolmitriptan
-
-
AstraZeneca Employees use Box to Drive Change through Innovation
Listen to David Smoley, Chief Information Officer, AstraZeneca discuss how Box has enabled the company to reinforce its cloud strategy. Learn more about our customers here: box.com/customers -
AstraZeneca Graduate Programme
Learn from AstraZeneca’s students about the exciting opportunities our graduate programmes have to offer. Learn more about how you can join us: http://www.astrazenecacareers.com/students/ -
Astrazeneca Commercial 2016 Super Bowl Commercial
Astrazeneca Commercial 2016 Super Bowl Commercial. In this Super Bowl 50 commercial, a man nervously sits in a cafe drinking a coffee when he hears the toilet flush in the background. The word "Envy" flashes on screen, and a smiling man walks out of the bathroom. Astrazeneca Commercial Astrazeneca super bowl Astrazeneca super bowl commercial Astrazeneca super bowl ad Astrazeneca super bowl 50 Astrazeneca super bowl 2016 Astrazeneca super bowl 2016 commercial Astrazeneca super bowl commercial 2016 Astrazeneca super bowl 50 commercial Astrazeneca ad #Astrazeneca #Commercial #2016 #Super #Bowl #Commercial https://www.youtube.com/channel/UCVPmZ9IrkSGUuCii7xPjiaQ -
AstraZeneca and MedImmune: Our Purpose
We push the boundaries of science to deliver life-changing medicines. -
AstraZeneca reveals designs for new Global R&D; Centre and Corporate Headquarters in Cambridge, UK
AstraZeneca today revealed the proposed designs for its new Global R&D; Centre and Corporate Headquarters in Cambridge in the UK. The plans for the new facility, which will be located on the Cambridge Biomedical Campus (CBC), include designs for the Global Centre, an R&D; Enabling Building and an Energy Centre. Read more at astrazeneca.com -
AstraZeneca's IMED Biotech Unit
Scientific achievement is full of endeavor and never giving up. Pushing the boundaries of science has led us to where we are today. The human genome project revolutionized medical science—giving the world detailed information about the structure, organization and function of the complete set of human genes. This is been pushing the boundaries of what is possible. At IMED—we share this approach and passion. Since 2010, we have built upon AstraZeneca’s strong heritage of drug discovery and development to lay the foundations for a bright future. From target identification to the end of phase two trials, our research is focused on our core therapy areas of oncology, respiratory and inflammation, cardiovascular and metabolic disease, while we remain optimistic in neuroscience and infection. ... -
AstraZeneca - Recruitment - Dave Smoley CIO
Listen to our Chief Information Officer, Dave Smoley, describe the exciting IT transformation journey happening at AstraZeneca! -
Employee Recognition at AstraZeneca
When leading global pharmaceutical company AstraZeneca decided to take a fresh look at what it meant to be an 'employer of choice' in its Australian operations in 2009, they went all out and decided to have a bit of fun in the process. They set out to create a strong culture of recognition across their remarkably diverse workforce and at the heart of their plans was a small blue mascot -- 'Charlie' -- who quickly became synonymous with recognition and reward. Four years on, he is still an immensely popular and recognisable figure across the organisation. -
Dapo Ajayi - AstraZeneca Chief Procurement Officer
Watch to find out what attracted Dapo Ajayi, Chief Procurement Officer at AstraZeneca to her CPO role, her vision for the future of procurement and more. Plus, click here to search jobs by career area to view open procurement positions at AstraZeneca: http://bit.ly/1ySKWng -
AstraZeneca's bucket problem | Lex
► Subscribe to the Financial Times on YouTube: http://bit.ly/FTimeSubs AstraZeneca has won extended US approval for a pipeline drug but, as Lex's Oliver Ralph and Robert Armstrong discuss, it needs more good news to stem its patent expiration problem. For more video content from the Financial Times, visit http://www.FT.com/video Twitter https://twitter.com/ftvideo Facebook https://www.facebook.com/financialtimes -
No deal means both AstraZeneca and Pfizer will lose
Pfizer's fourth and 'final' takeover approach for the UK pharmaceuticals group has been rejected. Lex's Joseph Cotterill and Robert Armstrong discuss where this leaves the two companies. For more video content from the Financial Times, visit http://www.FT.com/video Subscribe to the Financial Times on YouTube; http://goo.gl/vUQx5k Twitter https://twitter.com/ftvideo Facebook https://www.facebook.com/financialtimes -
PMQs: Cameron and Miliband on Pfizer AstraZeneca jobs
Labour leader Ed Miliband has called for the prime minister to give assurances on the future of AstraZeneca and possible job losses in Pfizer's bid for the UK firm. David Cameron said the best thing thing to do was "get stuck in to seek the best possible guarantees" on British jobs, investment and science. The pair clashed on job numbers and a possible break up of the firm, as they looked back to previous claims about the future of Cadbury and the Royal Mail -
AstraZeneca North West Apprenticeship Programme (UK)
Unsure if University is for you? Apply to one of AstraZeneca's apprenticeship programmes! With opportunities in engineering, technology and more, you'll work alongside our experts while being trained and mentored along the way. http://bit.ly/1TDnmFw -
Unique ABB robot solution increases throughput at AstraZeneca Australia
AstraZeneca Australia, is now relying on ABB robot technology to pack and palletise asthma medication to meet rising export demand. The ABB robots are part of an $80 million investment in six new production lines at AstraZeneca’s North Ryde facility in Sydney. -
AstraZeneca's move to the Cambridge Biomedical Campus
An introduction to AstraZeneca's new UK R&D; Centre and Global Corporate Headquarters, which will be part of the Cambridge Biomedical Campus, to the south of the city. AstraZeneca's Dr. Briggs Morrison, EVP Global Medicines Development & Chief Medical Officer, Dr. Mene Pangalos, EVP Innovative Medicines & Early Development and Dr. Bahija Jallal, EVP, Head of MedImmune comment on the significance of the move. External stakeholder viewpoints from Dr. Keith McNeil, Chief Executive, Cambridge University Hospitals, NHS Foundation Trust; Rt Hon Andrew Lansley, CBE, MP, Leader of the House of Commons and Member of Parliament, South Cambridgeshire, UK; Dr. Robert Winter, Managing Director, Eastern Academic Health Science Network, UK and Jeanette Walker, Project Director, Liberty Property Trust & Co... -
AstraZeneca Brasil Vídeo Institucional
A AstraZeneca é uma das maiores indústrias farmacêuticas do mundo e se dedica à pesquisa, desenvolvimento, fabricação e comercialização de produtos para venda com prescrição. Atua em diversos segmentos, como cardiovascular, respiratório, gastrointestinal, oncológico e neurológico. www.astrazeneca.com.br -
AstraZeneca - exclusive interview
Find out about the outlook for dividends, its drug pipeline and much more. -
MEDICAL - How cholesterol clogs your arteries (atherosclerosis)
To inform on the Atherosclerosis and its complex biological process: it is the idea of this project dedicated to the prevention of the cardiovascular risks of diseases. It was carried out by scientists and is adressed to general public. www.technicom-sa.fr -
EO Netwerk reportage: AstraZeneca verzwijgt dodelijke bijwerkingen Seroquel - deel 1
Deel 1/2 De top 3 meest dodelijke antipsychotica (Seroquel, Risperdal en Zyprexa) komt overeen met de top 3 meest voorgeschreven antipsychotica. De moderne antipsychotica zijn 10x duurder en tot 41% dodelijker dan de oude antipsychotica van 20 jaar geleden. Dat bleek in een grote studie gepubliceerd in The Lancet in 2009. http://dossiers.zielenknijper.nl/antipsychotica/ Antipsychotica is het meest winstgevende medicijn-type van de farmaceutische industrie. Antipsychotica verkort het leven met gemiddeld 25 tot 30 jaar volgens de officiële cijfers in de psychiatrie. Antipsychotica veroorzaakt hersenschade en vermindert daardoor de kans op herstel van psychose. Zonder behandeling hebben mensen 40% kans op herstel na 2 jaar. Met antipsychotica behandeling is de kans op herstel nehil en moe... -
"ENVY" TV Spot
Longing for a change? There may be more you can do about your Opioid-Induced Constipation (OIC). Visit http://www.OICisDifferent.com. The user generated content on this forum is not the opinion of or controlled by AstraZeneca. This site is intended for US consumers. ©2016 AstraZeneca. All rights reserved. 3216008 Last Updated 1/16 -
The AstraZeneca Brand film
What science can do. -
Reportage AstraZeneca
Videon är lånad ifrån http://www.life.astrazeneca.se/module.asp?XModuleId=16791 för ett skolarbete. "I videon får du följa två ungdomar från Mediegymnasiet när det gör ett reportage på AstraZeneca. Ungdomarna intervjuar veterinärer och djurtekniker som beskriver hur det är att jobba med djuren och varför djurförsöken är nödvändiga."
The AstraZeneca story
- Order: Reorder
- Duration: 3:46
- Updated: 15 Sep 2011
- views: 24766
Hear from our employees about AstraZeneca -- who we are, what we do and how we do it. Read more: http://www.astrazeneca.com/About-Us/Features
Hear from our employees about AstraZeneca -- who we are, what we do and how we do it. Read more: http://www.astrazeneca.com/About-Us/Features
wn.com/The Astrazeneca Story
AstraZeneca Employees use Box to Drive Change through Innovation
- Order: Reorder
- Duration: 2:56
- Updated: 15 Sep 2015
- views: 1824
Listen to David Smoley, Chief Information Officer, AstraZeneca discuss how Box has enabled the company to reinforce its cloud strategy. Learn more about our cus...
Listen to David Smoley, Chief Information Officer, AstraZeneca discuss how Box has enabled the company to reinforce its cloud strategy. Learn more about our customers here: box.com/customers
wn.com/Astrazeneca Employees Use Box To Drive Change Through Innovation
Listen to David Smoley, Chief Information Officer, AstraZeneca discuss how Box has enabled the company to reinforce its cloud strategy. Learn more about our customers here: box.com/customers
- published: 15 Sep 2015
- views: 1824
AstraZeneca Graduate Programme
- Order: Reorder
- Duration: 4:53
- Updated: 16 Sep 2015
- views: 1460
Learn from AstraZeneca’s students about the exciting opportunities our graduate programmes have to offer. Learn more about how you can join us: http://www.astra...
Learn from AstraZeneca’s students about the exciting opportunities our graduate programmes have to offer. Learn more about how you can join us: http://www.astrazenecacareers.com/students/
wn.com/Astrazeneca Graduate Programme
Learn from AstraZeneca’s students about the exciting opportunities our graduate programmes have to offer. Learn more about how you can join us: http://www.astrazenecacareers.com/students/
- published: 16 Sep 2015
- views: 1460
Astrazeneca Commercial 2016 Super Bowl Commercial
- Order: Reorder
- Duration: 2:17
- Updated: 08 Feb 2016
- views: 282
Astrazeneca Commercial 2016 Super Bowl Commercial. In this Super Bowl 50 commercial, a man nervously sits in a cafe drinking a coffee when he hears the toilet f...
Astrazeneca Commercial 2016 Super Bowl Commercial. In this Super Bowl 50 commercial, a man nervously sits in a cafe drinking a coffee when he hears the toilet flush in the background. The word "Envy" flashes on screen, and a smiling man walks out of the bathroom.
Astrazeneca Commercial
Astrazeneca super bowl
Astrazeneca super bowl commercial
Astrazeneca super bowl ad
Astrazeneca super bowl 50
Astrazeneca super bowl 2016
Astrazeneca super bowl 2016 commercial
Astrazeneca super bowl commercial 2016
Astrazeneca super bowl 50 commercial
Astrazeneca ad
#Astrazeneca
#Commercial
#2016
#Super
#Bowl
#Commercial
https://www.youtube.com/channel/UCVPmZ9IrkSGUuCii7xPjiaQ
wn.com/Astrazeneca Commercial 2016 Super Bowl Commercial
Astrazeneca Commercial 2016 Super Bowl Commercial. In this Super Bowl 50 commercial, a man nervously sits in a cafe drinking a coffee when he hears the toilet flush in the background. The word "Envy" flashes on screen, and a smiling man walks out of the bathroom.
Astrazeneca Commercial
Astrazeneca super bowl
Astrazeneca super bowl commercial
Astrazeneca super bowl ad
Astrazeneca super bowl 50
Astrazeneca super bowl 2016
Astrazeneca super bowl 2016 commercial
Astrazeneca super bowl commercial 2016
Astrazeneca super bowl 50 commercial
Astrazeneca ad
#Astrazeneca
#Commercial
#2016
#Super
#Bowl
#Commercial
https://www.youtube.com/channel/UCVPmZ9IrkSGUuCii7xPjiaQ
- published: 08 Feb 2016
- views: 282
AstraZeneca and MedImmune: Our Purpose
- Order: Reorder
- Duration: 1:32
- Updated: 11 Dec 2014
- views: 5311
We push the boundaries of science to deliver life-changing medicines.
We push the boundaries of science to deliver life-changing medicines.
wn.com/Astrazeneca And Medimmune Our Purpose
We push the boundaries of science to deliver life-changing medicines.
- published: 11 Dec 2014
- views: 5311
AstraZeneca reveals designs for new Global R&D; Centre and Corporate Headquarters in Cambridge, UK
- Order: Reorder
- Duration: 1:01
- Updated: 18 Jul 2014
- views: 10262
AstraZeneca today revealed the proposed designs for its new Global R&D; Centre and Corporate Headquarters in Cambridge in the UK. The plans for the new facility,...
AstraZeneca today revealed the proposed designs for its new Global R&D; Centre and Corporate Headquarters in Cambridge in the UK. The plans for the new facility, which will be located on the Cambridge Biomedical Campus (CBC), include designs for the Global Centre, an R&D; Enabling Building and an Energy Centre. Read more at astrazeneca.com
wn.com/Astrazeneca Reveals Designs For New Global R D Centre And Corporate Headquarters In Cambridge, UK
AstraZeneca today revealed the proposed designs for its new Global R&D; Centre and Corporate Headquarters in Cambridge in the UK. The plans for the new facility, which will be located on the Cambridge Biomedical Campus (CBC), include designs for the Global Centre, an R&D; Enabling Building and an Energy Centre. Read more at astrazeneca.com
- published: 18 Jul 2014
- views: 10262
AstraZeneca's IMED Biotech Unit
- Order: Reorder
- Duration: 2:19
- Updated: 14 Nov 2014
- views: 3574
Scientific achievement is full of endeavor and never giving up. Pushing the boundaries of science has led us to where we are today. The human genome project rev...
Scientific achievement is full of endeavor and never giving up. Pushing the boundaries of science has led us to where we are today. The human genome project revolutionized medical science—giving the world detailed information about the structure, organization and function of the complete set of human genes. This is been pushing the boundaries of what is possible. At IMED—we share this approach and passion.
Since 2010, we have built upon AstraZeneca’s strong heritage of drug discovery and development to lay the foundations for a bright future. From target identification to the end of phase two trials, our research is focused on our core therapy areas of oncology, respiratory and inflammation, cardiovascular and metabolic disease, while we remain optimistic in neuroscience and infection.
We have built a team of outstanding scientists with diverse experience and a broad range of skills driving forward research to push the boundaries of medical science. We are committed to create an environment that is open for collaboration for our people and our academic and biotech partners for scientific breakthroughs. We are fostering a culture where science thrives, one that is collaborative, agile, dynamic and entrepreneurial.
We have great pride in the breakthroughs we have made, the medicines we have developed, and the lives our science has saved. But the challenges that remain are the most complex and involved. Tackling them requires a new way of thinking. This is how we work, we do it in a way that reflects AstraZeneca’s shared values. It’s how we deliver life changing medicines to patients around the world.
wn.com/Astrazeneca's Imed Biotech Unit
Scientific achievement is full of endeavor and never giving up. Pushing the boundaries of science has led us to where we are today. The human genome project revolutionized medical science—giving the world detailed information about the structure, organization and function of the complete set of human genes. This is been pushing the boundaries of what is possible. At IMED—we share this approach and passion.
Since 2010, we have built upon AstraZeneca’s strong heritage of drug discovery and development to lay the foundations for a bright future. From target identification to the end of phase two trials, our research is focused on our core therapy areas of oncology, respiratory and inflammation, cardiovascular and metabolic disease, while we remain optimistic in neuroscience and infection.
We have built a team of outstanding scientists with diverse experience and a broad range of skills driving forward research to push the boundaries of medical science. We are committed to create an environment that is open for collaboration for our people and our academic and biotech partners for scientific breakthroughs. We are fostering a culture where science thrives, one that is collaborative, agile, dynamic and entrepreneurial.
We have great pride in the breakthroughs we have made, the medicines we have developed, and the lives our science has saved. But the challenges that remain are the most complex and involved. Tackling them requires a new way of thinking. This is how we work, we do it in a way that reflects AstraZeneca’s shared values. It’s how we deliver life changing medicines to patients around the world.
- published: 14 Nov 2014
- views: 3574
AstraZeneca - Recruitment - Dave Smoley CIO
- Order: Reorder
- Duration: 4:13
- Updated: 02 Sep 2014
- views: 2657
Listen to our Chief Information Officer, Dave Smoley, describe the exciting IT transformation journey happening at AstraZeneca!
Listen to our Chief Information Officer, Dave Smoley, describe the exciting IT transformation journey happening at AstraZeneca!
wn.com/Astrazeneca Recruitment Dave Smoley Cio
Listen to our Chief Information Officer, Dave Smoley, describe the exciting IT transformation journey happening at AstraZeneca!
- published: 02 Sep 2014
- views: 2657
Employee Recognition at AstraZeneca
- Order: Reorder
- Duration: 3:56
- Updated: 23 Feb 2014
- views: 2051
When leading global pharmaceutical company AstraZeneca decided to take a fresh look at what it meant to be an 'employer of choice' in its Australian operations...
When leading global pharmaceutical company AstraZeneca decided to take a fresh look at what it meant to be an 'employer of choice' in its Australian operations in 2009, they went all out and decided to have a bit of fun in the process. They set out to create a strong culture of recognition across their remarkably diverse workforce and at the heart of their plans was a small blue mascot -- 'Charlie' -- who quickly became synonymous with recognition and reward. Four years on, he is still an immensely popular and recognisable figure across the organisation.
wn.com/Employee Recognition At Astrazeneca
When leading global pharmaceutical company AstraZeneca decided to take a fresh look at what it meant to be an 'employer of choice' in its Australian operations in 2009, they went all out and decided to have a bit of fun in the process. They set out to create a strong culture of recognition across their remarkably diverse workforce and at the heart of their plans was a small blue mascot -- 'Charlie' -- who quickly became synonymous with recognition and reward. Four years on, he is still an immensely popular and recognisable figure across the organisation.
- published: 23 Feb 2014
- views: 2051
Dapo Ajayi - AstraZeneca Chief Procurement Officer
- Order: Reorder
- Duration: 3:45
- Updated: 19 Nov 2014
- views: 2375
Watch to find out what attracted Dapo Ajayi, Chief Procurement Officer at AstraZeneca to her CPO role, her vision for the future of procurement and more. Plus, ...
Watch to find out what attracted Dapo Ajayi, Chief Procurement Officer at AstraZeneca to her CPO role, her vision for the future of procurement and more. Plus, click here to search jobs by career area to view open procurement positions at AstraZeneca: http://bit.ly/1ySKWng
wn.com/Dapo Ajayi Astrazeneca Chief Procurement Officer
Watch to find out what attracted Dapo Ajayi, Chief Procurement Officer at AstraZeneca to her CPO role, her vision for the future of procurement and more. Plus, click here to search jobs by career area to view open procurement positions at AstraZeneca: http://bit.ly/1ySKWng
- published: 19 Nov 2014
- views: 2375
AstraZeneca's bucket problem | Lex
- Order: Reorder
- Duration: 2:29
- Updated: 05 Sep 2015
- views: 514
► Subscribe to the Financial Times on YouTube: http://bit.ly/FTimeSubs
AstraZeneca has won extended US approval for a pipeline drug but, as Lex's Oliver Ralph ...
► Subscribe to the Financial Times on YouTube: http://bit.ly/FTimeSubs
AstraZeneca has won extended US approval for a pipeline drug but, as Lex's Oliver Ralph and Robert Armstrong discuss, it needs more good news to stem its patent expiration problem.
For more video content from the Financial Times, visit http://www.FT.com/video
Twitter https://twitter.com/ftvideo
Facebook https://www.facebook.com/financialtimes
wn.com/Astrazeneca's Bucket Problem | Lex
► Subscribe to the Financial Times on YouTube: http://bit.ly/FTimeSubs
AstraZeneca has won extended US approval for a pipeline drug but, as Lex's Oliver Ralph and Robert Armstrong discuss, it needs more good news to stem its patent expiration problem.
For more video content from the Financial Times, visit http://www.FT.com/video
Twitter https://twitter.com/ftvideo
Facebook https://www.facebook.com/financialtimes
- published: 05 Sep 2015
- views: 514
No deal means both AstraZeneca and Pfizer will lose
- Order: Reorder
- Duration: 3:20
- Updated: 19 May 2014
- views: 1301
Pfizer's fourth and 'final' takeover approach for the UK pharmaceuticals group has been rejected. Lex's Joseph Cotterill and Robert Armstrong discuss where this...
Pfizer's fourth and 'final' takeover approach for the UK pharmaceuticals group has been rejected. Lex's Joseph Cotterill and Robert Armstrong discuss where this leaves the two companies.
For more video content from the Financial Times, visit http://www.FT.com/video
Subscribe to the Financial Times on YouTube; http://goo.gl/vUQx5k
Twitter https://twitter.com/ftvideo
Facebook https://www.facebook.com/financialtimes
wn.com/No Deal Means Both Astrazeneca And Pfizer Will Lose
Pfizer's fourth and 'final' takeover approach for the UK pharmaceuticals group has been rejected. Lex's Joseph Cotterill and Robert Armstrong discuss where this leaves the two companies.
For more video content from the Financial Times, visit http://www.FT.com/video
Subscribe to the Financial Times on YouTube; http://goo.gl/vUQx5k
Twitter https://twitter.com/ftvideo
Facebook https://www.facebook.com/financialtimes
- published: 19 May 2014
- views: 1301
PMQs: Cameron and Miliband on Pfizer AstraZeneca jobs
- Order: Reorder
- Duration: 8:39
- Updated: 14 May 2014
- views: 943
Labour leader Ed Miliband has called for the prime minister to give assurances on the future of AstraZeneca and possible job losses in Pfizer's bid for the UK f...
Labour leader Ed Miliband has called for the prime minister to give assurances on the future of AstraZeneca and possible job losses in Pfizer's bid for the UK firm.
David Cameron said the best thing thing to do was "get stuck in to seek the best possible guarantees" on British jobs, investment and science.
The pair clashed on job numbers and a possible break up of the firm, as they looked back to previous claims about the future of Cadbury and the Royal Mail
wn.com/Pmqs Cameron And Miliband On Pfizer Astrazeneca Jobs
Labour leader Ed Miliband has called for the prime minister to give assurances on the future of AstraZeneca and possible job losses in Pfizer's bid for the UK firm.
David Cameron said the best thing thing to do was "get stuck in to seek the best possible guarantees" on British jobs, investment and science.
The pair clashed on job numbers and a possible break up of the firm, as they looked back to previous claims about the future of Cadbury and the Royal Mail
- published: 14 May 2014
- views: 943
AstraZeneca North West Apprenticeship Programme (UK)
- Order: Reorder
- Duration: 5:52
- Updated: 10 Dec 2015
- views: 920
Unsure if University is for you? Apply to one of AstraZeneca's apprenticeship programmes! With opportunities in engineering, technology and more, you'll work al...
Unsure if University is for you? Apply to one of AstraZeneca's apprenticeship programmes! With opportunities in engineering, technology and more, you'll work alongside our experts while being trained and mentored along the way. http://bit.ly/1TDnmFw
wn.com/Astrazeneca North West Apprenticeship Programme (Uk)
Unsure if University is for you? Apply to one of AstraZeneca's apprenticeship programmes! With opportunities in engineering, technology and more, you'll work alongside our experts while being trained and mentored along the way. http://bit.ly/1TDnmFw
- published: 10 Dec 2015
- views: 920
Unique ABB robot solution increases throughput at AstraZeneca Australia
- Order: Reorder
- Duration: 4:01
- Updated: 21 Dec 2015
- views: 2267
AstraZeneca Australia, is now relying on ABB robot technology to pack and palletise asthma medication to meet rising export demand. The ABB robots are part of a...
AstraZeneca Australia, is now relying on ABB robot technology to pack and palletise asthma medication to meet rising export demand. The ABB robots are part of an $80 million investment in six new production lines at AstraZeneca’s North Ryde facility in Sydney.
wn.com/Unique Abb Robot Solution Increases Throughput At Astrazeneca Australia
AstraZeneca Australia, is now relying on ABB robot technology to pack and palletise asthma medication to meet rising export demand. The ABB robots are part of an $80 million investment in six new production lines at AstraZeneca’s North Ryde facility in Sydney.
- published: 21 Dec 2015
- views: 2267
AstraZeneca's move to the Cambridge Biomedical Campus
- Order: Reorder
- Duration: 3:09
- Updated: 18 Jun 2013
- views: 5078
An introduction to AstraZeneca's new UK R&D; Centre and Global Corporate Headquarters, which will be part of the Cambridge Biomedical Campus, to the south of the...
An introduction to AstraZeneca's new UK R&D; Centre and Global Corporate Headquarters, which will be part of the Cambridge Biomedical Campus, to the south of the city. AstraZeneca's Dr. Briggs Morrison, EVP Global Medicines Development & Chief Medical Officer, Dr. Mene Pangalos, EVP Innovative Medicines & Early Development and Dr. Bahija Jallal, EVP, Head of MedImmune comment on the significance of the move. External stakeholder viewpoints from Dr. Keith McNeil, Chief Executive, Cambridge University Hospitals, NHS Foundation Trust; Rt Hon Andrew Lansley, CBE, MP, Leader of the House of Commons and Member of Parliament, South Cambridgeshire, UK; Dr. Robert Winter, Managing Director, Eastern Academic Health Science Network, UK and Jeanette Walker, Project Director, Liberty Property Trust & Countryside Properties.
wn.com/Astrazeneca's Move To The Cambridge Biomedical Campus
An introduction to AstraZeneca's new UK R&D; Centre and Global Corporate Headquarters, which will be part of the Cambridge Biomedical Campus, to the south of the city. AstraZeneca's Dr. Briggs Morrison, EVP Global Medicines Development & Chief Medical Officer, Dr. Mene Pangalos, EVP Innovative Medicines & Early Development and Dr. Bahija Jallal, EVP, Head of MedImmune comment on the significance of the move. External stakeholder viewpoints from Dr. Keith McNeil, Chief Executive, Cambridge University Hospitals, NHS Foundation Trust; Rt Hon Andrew Lansley, CBE, MP, Leader of the House of Commons and Member of Parliament, South Cambridgeshire, UK; Dr. Robert Winter, Managing Director, Eastern Academic Health Science Network, UK and Jeanette Walker, Project Director, Liberty Property Trust & Countryside Properties.
- published: 18 Jun 2013
- views: 5078
AstraZeneca Brasil Vídeo Institucional
- Order: Reorder
- Duration: 4:41
- Updated: 11 Jul 2008
- views: 3597
A AstraZeneca é uma das maiores indústrias farmacêuticas do mundo e se dedica à pesquisa, desenvolvimento, fabricação e comercialização de produtos para venda c...
A AstraZeneca é uma das maiores indústrias farmacêuticas do mundo e se dedica à pesquisa, desenvolvimento, fabricação e comercialização de produtos para venda com prescrição. Atua em diversos segmentos, como cardiovascular, respiratório, gastrointestinal, oncológico e neurológico.
www.astrazeneca.com.br
wn.com/Astrazeneca Brasil Vídeo Institucional
A AstraZeneca é uma das maiores indústrias farmacêuticas do mundo e se dedica à pesquisa, desenvolvimento, fabricação e comercialização de produtos para venda com prescrição. Atua em diversos segmentos, como cardiovascular, respiratório, gastrointestinal, oncológico e neurológico.
www.astrazeneca.com.br
- published: 11 Jul 2008
- views: 3597
AstraZeneca - exclusive interview
- Order: Reorder
- Duration: 11:53
- Updated: 30 Oct 2015
- views: 2227
Find out about the outlook for dividends, its drug pipeline and much more.
Find out about the outlook for dividends, its drug pipeline and much more.
wn.com/Astrazeneca Exclusive Interview
Find out about the outlook for dividends, its drug pipeline and much more.
- published: 30 Oct 2015
- views: 2227
MEDICAL - How cholesterol clogs your arteries (atherosclerosis)
- Order: Reorder
- Duration: 5:37
- Updated: 22 Nov 2007
- views: 611856
To inform on the Atherosclerosis and its complex biological process: it is the idea of this project dedicated to the prevention of the cardiovascular risks of d...
To inform on the Atherosclerosis and its complex biological process: it is the idea of this project dedicated to the prevention of the cardiovascular risks of diseases. It was carried out by scientists and is adressed to general public.
www.technicom-sa.fr
wn.com/Medical How Cholesterol Clogs Your Arteries (Atherosclerosis)
To inform on the Atherosclerosis and its complex biological process: it is the idea of this project dedicated to the prevention of the cardiovascular risks of diseases. It was carried out by scientists and is adressed to general public.
www.technicom-sa.fr
- published: 22 Nov 2007
- views: 611856
EO Netwerk reportage: AstraZeneca verzwijgt dodelijke bijwerkingen Seroquel - deel 1
- Order: Reorder
- Duration: 10:01
- Updated: 09 Apr 2009
- views: 58317
Deel 1/2
De top 3 meest dodelijke antipsychotica (Seroquel, Risperdal en Zyprexa) komt overeen met de top 3 meest voorgeschreven antipsychotica. De moderne ant...
Deel 1/2
De top 3 meest dodelijke antipsychotica (Seroquel, Risperdal en Zyprexa) komt overeen met de top 3 meest voorgeschreven antipsychotica. De moderne antipsychotica zijn 10x duurder en tot 41% dodelijker dan de oude antipsychotica van 20 jaar geleden. Dat bleek in een grote studie gepubliceerd in The Lancet in 2009.
http://dossiers.zielenknijper.nl/antipsychotica/
Antipsychotica is het meest winstgevende medicijn-type van de farmaceutische industrie. Antipsychotica verkort het leven met gemiddeld 25 tot 30 jaar volgens de officiële cijfers in de psychiatrie.
Antipsychotica veroorzaakt hersenschade en vermindert daardoor de kans op herstel van psychose. Zonder behandeling hebben mensen 40% kans op herstel na 2 jaar. Met antipsychotica behandeling is de kans op herstel nehil en moet iemand het medicijn de rest van zijn leven blijven gebruiken.
The Journal of Nervous and Mental Disease, 195 (2007):406-414.
http://www.ncbi.nlm.nih.gov/pubmed/17502806
Alternatieve behandelinitiatieven zijn stelselmatig verdrukt. Als voorbeeld werd de subsidie van het onderzoek van de Amerikaanse hoogleraar Loren Mosher stopgezet toen het aantoonde dat 90% kans op goed herstel van schizofrenie mogelijk is met een psychotherapie gebaseerd op betekenisvolle intermenselijke relaties (vriendschap), zonder gebruik van antipsychotica, met minder kans op behandel-trauma, lagere behandelkosten, minder kans op terugval en met betere lange termijn resultaten in het sociale en academische leven.
http://www.independent.co.uk/life-style/health-and-families/health-news/schizophrenia-patients-denied-talking-therapies-921713.html
Hoogleraar Loren Mosher nam ontslag via een publieke brief aan de Amerikaanse Vereniging voor Psychiatrie (APA) en sprak daarin schande van wat hij noemde 'een antipsychotica-zwendel dat onnodig jonge levens verkwanselt'.
http://www.moshersoteria.com/
Zie ook de veelbelovende psychotherapie van Dr. Jaakko Seikkula uit Finland die ondanks de experimentele fase 80% kans op blijvend herstel van schizofrenie biedt zonder antipsychotica.
http://www.zielenknijper.nl/open-dialoog-finse-psychotherapie-blijkt-groot-succes-80-kans-herstel-van-schizofrenie-zonder-medicatie.html
wn.com/Eo Netwerk Reportage Astrazeneca Verzwijgt Dodelijke Bijwerkingen Seroquel Deel 1
Deel 1/2
De top 3 meest dodelijke antipsychotica (Seroquel, Risperdal en Zyprexa) komt overeen met de top 3 meest voorgeschreven antipsychotica. De moderne antipsychotica zijn 10x duurder en tot 41% dodelijker dan de oude antipsychotica van 20 jaar geleden. Dat bleek in een grote studie gepubliceerd in The Lancet in 2009.
http://dossiers.zielenknijper.nl/antipsychotica/
Antipsychotica is het meest winstgevende medicijn-type van de farmaceutische industrie. Antipsychotica verkort het leven met gemiddeld 25 tot 30 jaar volgens de officiële cijfers in de psychiatrie.
Antipsychotica veroorzaakt hersenschade en vermindert daardoor de kans op herstel van psychose. Zonder behandeling hebben mensen 40% kans op herstel na 2 jaar. Met antipsychotica behandeling is de kans op herstel nehil en moet iemand het medicijn de rest van zijn leven blijven gebruiken.
The Journal of Nervous and Mental Disease, 195 (2007):406-414.
http://www.ncbi.nlm.nih.gov/pubmed/17502806
Alternatieve behandelinitiatieven zijn stelselmatig verdrukt. Als voorbeeld werd de subsidie van het onderzoek van de Amerikaanse hoogleraar Loren Mosher stopgezet toen het aantoonde dat 90% kans op goed herstel van schizofrenie mogelijk is met een psychotherapie gebaseerd op betekenisvolle intermenselijke relaties (vriendschap), zonder gebruik van antipsychotica, met minder kans op behandel-trauma, lagere behandelkosten, minder kans op terugval en met betere lange termijn resultaten in het sociale en academische leven.
http://www.independent.co.uk/life-style/health-and-families/health-news/schizophrenia-patients-denied-talking-therapies-921713.html
Hoogleraar Loren Mosher nam ontslag via een publieke brief aan de Amerikaanse Vereniging voor Psychiatrie (APA) en sprak daarin schande van wat hij noemde 'een antipsychotica-zwendel dat onnodig jonge levens verkwanselt'.
http://www.moshersoteria.com/
Zie ook de veelbelovende psychotherapie van Dr. Jaakko Seikkula uit Finland die ondanks de experimentele fase 80% kans op blijvend herstel van schizofrenie biedt zonder antipsychotica.
http://www.zielenknijper.nl/open-dialoog-finse-psychotherapie-blijkt-groot-succes-80-kans-herstel-van-schizofrenie-zonder-medicatie.html
- published: 09 Apr 2009
- views: 58317
"ENVY" TV Spot
- Order: Reorder
- Duration: 1:03
- Updated: 05 Feb 2016
- views: 28056
Longing for a change? There may be more you can do about your Opioid-Induced Constipation (OIC). Visit http://www.OICisDifferent.com.
The user generated conten...
Longing for a change? There may be more you can do about your Opioid-Induced Constipation (OIC). Visit http://www.OICisDifferent.com.
The user generated content on this forum is not the opinion of or controlled by AstraZeneca.
This site is intended for US consumers. ©2016 AstraZeneca. All rights reserved. 3216008 Last Updated 1/16
wn.com/Envy Tv Spot
Longing for a change? There may be more you can do about your Opioid-Induced Constipation (OIC). Visit http://www.OICisDifferent.com.
The user generated content on this forum is not the opinion of or controlled by AstraZeneca.
This site is intended for US consumers. ©2016 AstraZeneca. All rights reserved. 3216008 Last Updated 1/16
- published: 05 Feb 2016
- views: 28056
The AstraZeneca Brand film
- Order: Reorder
- Duration: 1:21
- Updated: 26 Oct 2015
- views: 485
What science can do.
What science can do.
wn.com/The Astrazeneca Brand Film
What science can do.
- published: 26 Oct 2015
- views: 485
Reportage AstraZeneca
- Order: Reorder
- Duration: 11:45
- Updated: 03 May 2011
- views: 3428
Videon är lånad ifrån http://www.life.astrazeneca.se/module.asp?XModuleId=16791 för ett skolarbete.
"I videon får du följa två ungdomar från Mediegymnasiet när...
Videon är lånad ifrån http://www.life.astrazeneca.se/module.asp?XModuleId=16791 för ett skolarbete.
"I videon får du följa två ungdomar från Mediegymnasiet när det gör ett reportage på AstraZeneca. Ungdomarna intervjuar veterinärer och djurtekniker som beskriver hur det är att jobba med djuren och varför djurförsöken är nödvändiga."
wn.com/Reportage Astrazeneca
Videon är lånad ifrån http://www.life.astrazeneca.se/module.asp?XModuleId=16791 för ett skolarbete.
"I videon får du följa två ungdomar från Mediegymnasiet när det gör ett reportage på AstraZeneca. Ungdomarna intervjuar veterinärer och djurtekniker som beskriver hur det är att jobba med djuren och varför djurförsöken är nödvändiga."
- published: 03 May 2011
- views: 3428
close fullscreen
- Playlist
- Chat
close fullscreen
- Playlist
- Chat
3:46
The AstraZeneca story
Hear from our employees about AstraZeneca -- who we are, what we do and how we do it. Read...
published: 15 Sep 2011
The AstraZeneca story
The AstraZeneca story
- Report rights infringement
- published: 15 Sep 2011
- views: 24766
2:56
AstraZeneca Employees use Box to Drive Change through Innovation
Listen to David Smoley, Chief Information Officer, AstraZeneca discuss how Box has enabled...
published: 15 Sep 2015
AstraZeneca Employees use Box to Drive Change through Innovation
AstraZeneca Employees use Box to Drive Change through Innovation
- Report rights infringement
- published: 15 Sep 2015
- views: 1824
4:53
AstraZeneca Graduate Programme
Learn from AstraZeneca’s students about the exciting opportunities our graduate programmes...
published: 16 Sep 2015
AstraZeneca Graduate Programme
AstraZeneca Graduate Programme
- Report rights infringement
- published: 16 Sep 2015
- views: 1460
2:17
Astrazeneca Commercial 2016 Super Bowl Commercial
Astrazeneca Commercial 2016 Super Bowl Commercial. In this Super Bowl 50 commercial, a man...
published: 08 Feb 2016
Astrazeneca Commercial 2016 Super Bowl Commercial
Astrazeneca Commercial 2016 Super Bowl Commercial
- Report rights infringement
- published: 08 Feb 2016
- views: 282
1:32
AstraZeneca and MedImmune: Our Purpose
We push the boundaries of science to deliver life-changing medicines.
published: 11 Dec 2014
AstraZeneca and MedImmune: Our Purpose
AstraZeneca and MedImmune: Our Purpose
- Report rights infringement
- published: 11 Dec 2014
- views: 5311
1:01
AstraZeneca reveals designs for new Global R&D; Centre and Corporate Headquarters in Cambridge, UK
AstraZeneca today revealed the proposed designs for its new Global R&D; Centre and Corporat...
published: 18 Jul 2014
AstraZeneca reveals designs for new Global R&D; Centre and Corporate Headquarters in Cambridge, UK
AstraZeneca reveals designs for new Global R&D; Centre and Corporate Headquarters in Cambridge, UK
- Report rights infringement
- published: 18 Jul 2014
- views: 10262
2:19
AstraZeneca's IMED Biotech Unit
Scientific achievement is full of endeavor and never giving up. Pushing the boundaries of ...
published: 14 Nov 2014
AstraZeneca's IMED Biotech Unit
AstraZeneca's IMED Biotech Unit
- Report rights infringement
- published: 14 Nov 2014
- views: 3574
4:13
AstraZeneca - Recruitment - Dave Smoley CIO
Listen to our Chief Information Officer, Dave Smoley, describe the exciting IT transformat...
published: 02 Sep 2014
AstraZeneca - Recruitment - Dave Smoley CIO
AstraZeneca - Recruitment - Dave Smoley CIO
- Report rights infringement
- published: 02 Sep 2014
- views: 2657
3:56
Employee Recognition at AstraZeneca
When leading global pharmaceutical company AstraZeneca decided to take a fresh look at wha...
published: 23 Feb 2014
Employee Recognition at AstraZeneca
Employee Recognition at AstraZeneca
- Report rights infringement
- published: 23 Feb 2014
- views: 2051
3:45
Dapo Ajayi - AstraZeneca Chief Procurement Officer
Watch to find out what attracted Dapo Ajayi, Chief Procurement Officer at AstraZeneca to h...
published: 19 Nov 2014
Dapo Ajayi - AstraZeneca Chief Procurement Officer
Dapo Ajayi - AstraZeneca Chief Procurement Officer
- Report rights infringement
- published: 19 Nov 2014
- views: 2375
2:29
AstraZeneca's bucket problem | Lex
► Subscribe to the Financial Times on YouTube: http://bit.ly/FTimeSubs
AstraZeneca has wo...
published: 05 Sep 2015
AstraZeneca's bucket problem | Lex
AstraZeneca's bucket problem | Lex
- Report rights infringement
- published: 05 Sep 2015
- views: 514
3:20
No deal means both AstraZeneca and Pfizer will lose
Pfizer's fourth and 'final' takeover approach for the UK pharmaceuticals group has been re...
published: 19 May 2014
No deal means both AstraZeneca and Pfizer will lose
No deal means both AstraZeneca and Pfizer will lose
- Report rights infringement
- published: 19 May 2014
- views: 1301
8:39
PMQs: Cameron and Miliband on Pfizer AstraZeneca jobs
Labour leader Ed Miliband has called for the prime minister to give assurances on the futu...
published: 14 May 2014
PMQs: Cameron and Miliband on Pfizer AstraZeneca jobs
PMQs: Cameron and Miliband on Pfizer AstraZeneca jobs
- Report rights infringement
- published: 14 May 2014
- views: 943
5:52
AstraZeneca North West Apprenticeship Programme (UK)
Unsure if University is for you? Apply to one of AstraZeneca's apprenticeship programmes! ...
published: 10 Dec 2015
AstraZeneca North West Apprenticeship Programme (UK)
AstraZeneca North West Apprenticeship Programme (UK)
- Report rights infringement
- published: 10 Dec 2015
- views: 920
The AstraZeneca story...
AstraZeneca Employees use Box to Drive Change thro...
AstraZeneca Graduate Programme...
Astrazeneca Commercial 2016 Super Bowl Commercial...
AstraZeneca and MedImmune: Our Purpose...
AstraZeneca reveals designs for new Global R&D; Cen...
AstraZeneca's IMED Biotech Unit...
AstraZeneca - Recruitment - Dave Smoley CIO...
Employee Recognition at AstraZeneca...
Dapo Ajayi - AstraZeneca Chief Procurement Officer...
AstraZeneca's bucket problem | Lex...
No deal means both AstraZeneca and Pfizer will los...
PMQs: Cameron and Miliband on Pfizer AstraZeneca j...
AstraZeneca North West Apprenticeship Programme (U...
Unique ABB robot solution increases throughput at ...
AstraZeneca's move to the Cambridge Biomedical Cam...
AstraZeneca Brasil Vídeo Institucional...
AstraZeneca - exclusive interview...
MEDICAL - How cholesterol clogs your arteries (ath...
EO Netwerk reportage: AstraZeneca verzwijgt dodeli...
"ENVY" TV Spot...
The AstraZeneca Brand film...
Reportage AstraZeneca...
photo: Via Youtube / GALAXIAN HD
Woman seems to vanish on live TV in viral video that has baffled the Internet
Edit Atlanta Journal 20 Mar 2016
Are you ready to watch this clip over and over again?. A man was being interviewed at an airport’s baggage claim area for a live news report on Danish TV2’s Sports Center when a woman in the background appeared to vanish. The video shows a blonde woman on the left side of the screen simply disappearing when another woman pushing a trolley walks past her.Video still via Danny Archer / YouTube ... By ... ....
photo: AP / Mohammad Sajjad
Boy wearing ‘monster mask’ shot by guard in Karachi
Edit Dawn 21 Mar 2016
KARACHI. An 11-year-old boy, wearing ‘monster mask’, was shot dead by a security guard in Ferozabad area on Sunday night, according to police ... ....
photo: Via YouTube
North Korea has fired 5 short-range projectiles into the sea
Edit Business Insider 21 Mar 2016
North Korea fired five short-range projectiles into the sea off its east coast on Monday, South Korea's military said, amid heightened tension over the isolated country's nuclear and rocket programs ... On Friday, North Korea fired two mid-range ballistic missiles into the sea in defiance of tough new U.N. and U.S ... ....
photo: USMC / Lance Cpl. Dalton A. Precht
US sends in Marines to join ground fight against ISIS in Iraq
Edit The Times of India 21 Mar 2016
A detachment of US Marines has been dispatched to Iraq to join the ground fight against ISIS. The Marines sent are from the 26th Marine Expeditionary Unit (MEU), an air-ground fighting force of 2,200 soldiers. However, it is not clear how many of these soldiers will actually be deployed to Iraq. There are around 3,600 US army personnel already stationed in Iraq ... A US sergeant was killed in the assault ... I want to be clear about that." ... ....
photo: AP / Ross D. Franklin
The Future Is Populism, Expect More Violence
Edit WorldNews.com 21 Mar 2016
Article by WN.com Correspondent Dallas DarlingDon’t be surprised if more protesters at Trump rallies are viciously assaulted, like the one that occurred on Saturday in Tucson, Ariz.Indeed, politics always presupposes violence. In fact, a major concern that motivates people to either form a popular movement or a new state in which some type of law and order is entrusted to a central authority is violence....
« back to news headlines
Four Fab 5% Yielders! AstraZeneca plc, Standard Life Plc, eSure Group PLC & Vodafone Group plc
Edit The Motley Fool 21 Mar 2016
I believe the dependable nature of medicines demand should power earnings — and consequently dividends — at pharma giant AstraZeneca (LSE ... Sure, the issue of patent losses on key labels is set to remain an anchor around the bottom line for some time yet — the City expects AstraZeneca to rack up further bottom-line slides in 2016 and 2017 ... The Motley Fool UK has recommended AstraZeneca....
Sainsbury's boosts FTSE as Home Retail rival pulls out
Edit Citywire 21 Mar 2016
Sainsbury's has led the FTSE 100 higher after the supermarket was given a clear run to buy Argos owner Home Retail Group following rival suitor Steinhoff International's withdrawal from the race ... Pharmaceutical stocks were also in the ascendancy, with Shire (SHP) the top riser, up 3.1% at £38.07, Hikma Pharmaceuticals (HIK) up 1.6% at £18.57 and AstraZeneca (AZN) adding 1% to £39.27 ... ....
Teligent, Inc. Announces Launch Of Cefotan® (Cefotetan For Injection) (Teligent Inc)
Edit Public Technologies 21 Mar 2016
(Source. Teligent Inc). BUENA, N.J., March 21, 2016/PRNewswire / -- Teligent, Inc. (NASDAQ ... This is the Company's first product launched from the portfolio of discontinued and withdrawn new drug applications (NDAs) and abbreviated new drug applications (ANDAs), which the Company purchased from AstraZeneca on September 25, 2014 ... ''This is our first product launch that will start to address the drug shortage concerns in the United States.'....
Emakina results 2015: a very good performance (Emakina Group SA)
Edit Public Technologies 21 Mar 2016
(Source ... Press release Emakina results 2015 ... Key figures ... 2014 ... AstraZeneca, Bosch Siemens, Celio, Carré de l'Habitat, Cofely (Engie), Crea Geneve, Crédit Mutuel Arkéa, De Lijn, European Defence Agency, Floris van Bommel, Generali, Goodman, Greentube, Hypo NÖ, Jimmy Choo, Kenwood, Kiala (UPS), Lola & Lisa, Markafoni, Melexis, Merck, Merkur Markt (REWE), Vecos, WE Fashion and brands in the Ales group, such as Caron, Lierac and Phyto....
How GlaxoSmithKline Shareholders Will Benefit From Today’s Low Prices
Edit The Motley Fool 19 Mar 2016
GSK), you should be cheering lower prices ... GlaxoSmithKline plc, Diageo plc And PZ Cussons plc Grab A 5% Yield With GlaxoSmithKline plc, Standard Life Plc And Tate & Lyle PLC Are Drugmakers GlaxoSmithKline Plc & AstraZeneca Plc The Cure For Poor Returns? ... ....
A new model for training scientists could create a conflict of interest
Edit The Washington Post 19 Mar 2016
(Rachel Orr/The Washington Post). A new partnership between Johns Hopkins University and biotech company MedImmune to train scientists is raising pointed questions from critics about potential conflicts of interest ... Johns Hopkins-MedImmune Scholars will have two research mentors -- one at the company, the Gaithersburg research arm of pharmaceutical giant AstraZeneca, and one at Johns Hopkins ... that hasn’t really been an issue." ... ....
Is It Time To Dump AstraZeneca plc And Buy Hikma Pharmaceuticals Plc And Shire PLC?
Edit The Motley Fool 18 Mar 2016
Although many investors may feel that AstraZeneca (LSE ... AstraZeneca has engaged in M&A; activity and has the cash flow and balance sheet to continue to do so in the coming years ... While the process of turning AstraZeneca around is a rather gradual one, it offers excellent income prospects in the meantime ... Peter Stephens owns shares of AstraZeneca. The Motley Fool UK has recommended AstraZeneca and Hikma Pharmaceuticals....
BT shares rise as it appoints new finance director
Edit The Guardian 18 Mar 2016
... programmes.” As well as BG, he has been a director at ScottishPower and AstraZeneca, and has been a non-executive at Standard Chartered since 2010....
Growth From ARM Holdings plc Or Dividends From British American Tobacco plc, Which Is Best?
Edit The Motley Fool 18 Mar 2016
ARM) ... Steady cash ... It’s not that simple ... Which is better? ... AstraZeneca plc, BT Group plc And British American Tobacco plc Are ARM Holdings plc, Imagination Technologies Group plc, Quarto Group Inc And Cello Group plc Set To Soar? Apple Inc ... Which Is The Better Tech Titan? Am I Nuts Being Out Of AstraZeneca plc, British American Tobacco plc And BP plc? Are These The FTSE’s Safest Dividends? British American Tobacco plc, A.G ... ....
Thanks to all our Annual Conference supporters! (Ohio Pharmacists Association)
Edit Public Technologies 18 Mar 2016
(Source. Ohio Pharmacists Association). Complete Story. At the OPA 138 Annual Conference and Trade Show, more than 1000 pharmacist and student pharmacist attendees are expected to come and learn about your products and services to improve outcomes of their patients. In Ohio, attendees also have a chance to win prizes. Prizes, which are donated by our exhibitors, include iPods, TV's, pharmacy prints and much more ... Exhibitors ... AstraZeneca....
Can Shares of Minnows Premier Oil Plc & EnQuest Plc Catch Supermajor BP Plc?
Edit The Motley Fool 18 Mar 2016
Not quite Premier division ... More reading Should You Buy SOCO International plc And Sell Enquest Plc And Gulf Keystone Petroleum Limited? Will BP plc Ever Return To Its Pre-Crisis High Of 650p? Do Budget Changes Make Premier Oil PLC, Nichols plc and Britvic Plc A Buy? Am I Nuts Being Out Of AstraZeneca plc, British American Tobacco plc And BP plc? Have 88 Energy Ltd, Premier Oil PLC And Petrofac Limited Finally Turned A Corner? ... ....
Omnis Pharma and Magnis Therapeutics Merge to Form Vyriad, a Clinical-Stage Oncolytic Immunovirotherapy Development Company -- Combined entity aims to be a leader in oncolytic virotherapy discovery, development, and commercialization ---- Pipeline of immuno-oncology products targets a broad range of cancers --
Edit PR Newswire 18 Mar 2016
ROCHESTER, Minn., March 18, 2016 /PRNewswire/ -- Omnis Pharma, Inc ... Partnerships. Vyriad partnership agreements include a licensing agreement with MedImmune/AstraZeneca focused on pairing Vyriad's oncolytic VSV virus with a checkpoint inhibitor created by MedImmune; and a collaborative research and development agreement with Profectus BioSciences focused on developing oncolytic recombinant VSV vaccines for cancer immunotherapy ... Dr....
Should Unilever plc, BT Group plc And Centrica PLC Be In Your 2016 ISA?
Edit The Motley Fool 18 Mar 2016
ULVR) ... Technology too? ... AstraZeneca plc, BT Group plc And British American Tobacco plc Balfour Beatty plc Set To Reinstate Dividend (And Rival National Grid plc And Centrica PLC Once More?) 3 Ultra-Reliable Dividend Stocks? Unilever plc, Pennon Group plc And Royal Mail PLC Will Faltering Emerging Markets Drag Down Unilever Plc, Standard Chartered Plc & Prudential Plc? More Pain Could Lie Ahead For BT Group plc, Next plc And Greggs plc....
- 1
- 2
- 3
- 4
- 5
- Next page »
